Michael Mullen

ORCID: 0000-0002-4911-3511
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Congenital Heart Disease Studies
  • Aortic Disease and Treatment Approaches
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Cardiovascular and Diving-Related Complications
  • Cardiovascular Health and Disease Prevention
  • Cardiac Arrhythmias and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiac pacing and defibrillation studies
  • Connective tissue disorders research
  • Coronary Interventions and Diagnostics
  • Pulmonary Hypertension Research and Treatments
  • Blood Pressure and Hypertension Studies
  • Cardiac Structural Anomalies and Repair
  • Cerebrovascular and Carotid Artery Diseases
  • Nitric Oxide and Endothelin Effects
  • Cardiac and Coronary Surgery Techniques
  • Cardiac, Anesthesia and Surgical Outcomes
  • Reservoir Engineering and Simulation Methods
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Atrial Fibrillation Management and Outcomes
  • Cardiomyopathy and Myosin Studies
  • Hydraulic Fracturing and Reservoir Analysis

St Bartholomew's Hospital
2007-2025

Barts Health NHS Trust
2016-2024

British Heart Foundation
2016-2024

University College London
2013-2023

John Wiley & Sons (United States)
2023

Art Research Centre of the Slovak Academy of Sciences
2018-2021

University of Kentucky
2011-2021

Queen Mary University of London
2019-2021

William Harvey Research Institute
2021

University College Hospital at Westmoreland Street
2005-2018

Background —Patients with chronic heart failure (CHF) have a continuing high mortality. Autonomic dysfunction may play an important role in the pathophysiology of cardiac death CHF. UK-HEART examined value rate variability (HRV) measures as independent predictors Methods and Results —In prospective study powered for mortality, we recruited 433 outpatients 62±9.6 years old CHF (NYHA functional class I to III; mean ejection fraction, 0.41±0.17). Time-domain HRV indices conventional prognostic...

10.1161/01.cir.98.15.1510 article EN Circulation 1998-10-13

The objective was to define the characteristics of a real-world patient population treated with transcatheter aortic valve implantation (TAVI), regardless technology or access route, and evaluate their clinical outcome over mid long term. Although substantial body data exists in relation early outcomes after TAVI, there are few on beyond 1 year any notable number patients. U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry established report all procedures performed...

10.1016/j.jacc.2011.08.050 article EN publisher-specific-oa Journal of the American College of Cardiology 2011-10-24

Background— Although some patients with adult congenital heart disease (ACHD) report limitations in exercise capacity, we hypothesized that depressed capacity may be more widespread than superficially evident during clinical consultation and could a means of assessing risk. Methods Results— Cardiopulmonary testing was performed 335 consecutive ACHD (age, 33±13 years), 40 non–congenital failure 58±15 11 young 29±5 years) 12 older 59±9 healthy subjects. Peak oxygen consumption (peak V̇ o 2 )...

10.1161/circulationaha.104.529800 article EN Circulation 2005-08-02

Background —Mental stress has been linked to increased morbidity and mortality in coronary artery disease atherosclerosis progression. Experimental studies have suggested that damage the endothelium may be an important mechanism. Methods Results —Endothelial function was studied 10 healthy men (aged 50.4±9.6 years) 8 non–insulin-dependent diabetic 52.0±7.2 years). Brachial flow-mediated dilation (FMD, dependent) response 50 μg of sublingual glyceryl trinitrate (GTN, independent) were...

10.1161/01.cir.102.20.2473 article EN Circulation 2000-11-14

Background —We tested the hypothesis that endothelial dysfunction underlies association between an acute inflammatory episode and transiently increased risk of a cardiovascular event by examining effects experimental stimulus on endothelium-dependent vasodilation. Methods Results — Salmonella typhi vaccine was used to generate systemic response in healthy volunteers. In 12 subjects, dilatation brachial artery flow sublingual nitroglycerin (NTG) recorded (conduit vessel response), 6 venous...

10.1161/01.cir.102.9.994 article EN Circulation 2000-08-29

Patent foramen ovale (PFO) is prevalent in patients with migraine aura. Observational studies show that PFO closure resulted cessation or improvement approximately 80% of such patients. We investigated the effects for a randomized, double-blind, sham-controlled trial.Patients who suffered from aura, experienced frequent attacks, had previously failed > = 2 classes prophylactic treatments, and moderate large right-to-left shunts consistent presence were randomized to transcatheter STARFlex...

10.1161/circulationaha.107.727271 article EN Circulation 2008-03-04

Abstract —Flow-mediated dilatation (FMD) of conduit arteries is dependent on an intact endothelium, although the mechanisms are not fully understood. Using high-resolution ultrasound, we examined role endothelial mediators in radial artery response to transient (short period reactive hyperemia) and sustained (prolonged hyperemia, hand warming, or incremental infusion acetylcholine into distal artery) hyperemia. After short episodes FMD was abolished by local nitric oxide synthesis inhibitor...

10.1161/01.res.88.2.145 article EN Circulation Research 2001-02-02

Permanent pacemaker (PPM) requirement is a recognized complication of transcatheter aortic valve implantation. We assessed the UK incidence permanent pacing within 30 days CoreValve implantation and formulated an anatomic electrophysiological model.Data from 270 patients at 10 centers in United Kingdom were examined. Twenty-five (8%) had preexisting PPMs; 2 incomplete data. The remaining 243 81.3±6.7 years age; 50.6% male. QRS duration increased 105±23 to 135±29 milliseconds (P<0.01). Left...

10.1161/circulationaha.109.927152 article EN Circulation 2011-02-22

Older patients with severe aortic stenosis (AS) are increasingly identified as having cardiac amyloidosis (CA). It is unknown whether concomitant AS-CA has worse outcomes or results in futility of transcatheter valve replacement (TAVR).This study clinical characteristics and compared lone AS.Patients who were referred for TAVR at 3 international sites underwent blinded research core laboratory 99mtechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) bone scintigraphy (Perugini grade...

10.1016/j.jacc.2020.11.006 article EN cc-by-nc-nd Journal of the American College of Cardiology 2020-11-09

Cardiac amyloidosis is common in elderly patients with aortic stenosis (AS) referred for transcatheter valve implantation (TAVI). We hypothesized that dual and cardiac amyloid pathology (AS-amyloid) would have different baseline characteristics, periprocedural mortality outcomes.Patients aged ≥75 severe AS TAVI at two sites underwent blinded bone scintigraphy prior to intervention (Perugini Grade 0 negative, 1-3 increasingly positive). Baseline assessment included echocardiography,...

10.1093/eurheartj/ehaa170 article EN cc-by European Heart Journal 2020-02-27

Background —Endothelial dysfunction leading to neutrophil infiltration of tissues has been implicated in tissue injury caused by ischemia-reperfusion (IR). Tissue during IR can be reduced prior ischemic preconditioning (IPC). In humans, it is unclear whether endothelial occurs or IPC offers protection against and inflammatory cell activation. We studied the effects experimental on function human forearm vivo examined afforded IPC. Method Results —The was made for 20 minutes inflating a blood...

10.1161/01.cir.103.12.1624 article EN Circulation 2001-03-27

Paravalvular leak (PVL) occurs in 5% to 17% of patients following surgical valve replacement. Percutaneous device closure represents an alternative repeat surgery.All UK and Ireland centers undertaking percutaneous PVL submitted data the Registry. Data were analyzed for association with death major adverse cardiovascular events (MACE) at follow-up.Three hundred eight procedures attempted 259 20 (2004-2015). Patient age was 67±13 years; 28% female. The main indications heart failure (80%)...

10.1161/circulationaha.116.022684 article EN Circulation 2016-09-02

Irbesartan, a long acting selective angiotensin-1 receptor inhibitor, in Marfan syndrome might reduce aortic dilatation, which is associated with dissection and rupture. We aimed to determine the effects of irbesartan on rate dilatation children adults syndrome.We did placebo-controlled, double-blind randomised trial at 22 centres UK. Individuals aged 6-40 years clinically confirmed were eligible for inclusion. Study participants all given 75 mg open label once daily, then randomly assigned...

10.1016/s0140-6736(19)32518-8 article EN cc-by The Lancet 2019-12-01

Postinfarction ventricular septal defect carries a grim prognosis. Surgical repair offers reasonable outcomes in patients who survive healing phase. Percutaneous device implantation represents potentially attractive early alternative.Postinfarction closure was attempted 53 from 11 centers (1997-2012; aged 72±11 years; 42% female). Nineteen percent had previous surgical closure. Myocardial infarction anterior (66%) or inferior (34%). Time myocardial to procedure 13 (first and third quartiles,...

10.1161/circulationaha.113.005839 article EN Circulation 2014-03-26
Arthur Pancioli Opeolu Adeoye Pamela Schmit Jane Khoury Steven R. Levine and 95 more Thomas A. Tomsick Heidi Sucharew Claudette E. Brooks Todd J. Crocco Laurie Gutmann Thomas Hemmen Scott E. Kasner Dawn Kleindorfer William A. Knight Sharyl Martini James S. McKinney William J. Meurer Brett C. Meyer Alexander Schneider Phillip Scott Sidney Starkman Steven Warach Joseph P. Broderick Arthur Pancioli Opeolu Adeoye Joseph P. Broderick Pamela Schmit Jane Khoury Heidi Sucharew Scott Janis Thomas A. Tomsick Claudette E. Brooks Todd J. Crocco Thomas Hemmen Scott E. Kasner James S. McKinney William J. Meurer Alex Schneider Sidney Starkman Steven Warach Steven R. Levine Claudia S. Moy K.M.A. Welch Gretchen E. Tietjen William R. Clarke Jordan Bonomo Erin McDonough Simona Ferioli Felipe de los Rios De la Rosa Sharyl Martini Daniel Woo Rachel Garvin Dawn Kleindorfer Pooja Khatri Anna Gensic Matthew L. Flaherty Daniel Kanter Brett Kissela Brian Stettler Jason Mackey Rhonda Cadena Shannon Kohake Laura Heitsch Samir Belagaje Achala Vagal John M. Hallenbeck Richard Benson Amie W. Hsia Rakesh Jaitly Lawrence L. Latour John Lynch José Luís Merino Ravi S. Menon Jason Freeman Alejandro Magadán Nandakumar Magaraja Jennifer Jothen Bonanle Famakin Shlee Song Alex Katcheves Zurab Nadareishvili C L Ritter William G. Barsan Devin Brown Lewis B. Morgenstern Robert Silbergleit Venkatakrishna Rajajee Lesli Rusche-Skolarus J. R. Burke Jeffrey J. Fletcher Eric E. Adelman Michael Ke Wang Darin Zahuranec Brett Cucchiara Steven R. Messé Christina Wilson Koto Ishida Michael Mullen Jonathan M. Raser Swaroop Pawar

In a previous study, 0.3 and 0.45 mg/kg of intravenous recombinant tissue plasminogen activator (rt-PA) were safe when combined with eptifibatide 75 mcg/kg bolus 2-hour infusion (0.75 per minute). The Combined Approach to Lysis Utilizing Eptifibatide rt-PA in Acute Ischemic Stroke-Enhanced Regimen (CLEAR-ER) trial sought determine the safety higher-dose regimen establish evidence for phase III trial.CLEAR-ER was multicenter, double-blind, randomized study. stroke patients 0.6 plus (135 at...

10.1161/strokeaha.113.001059 article EN Stroke 2013-07-26

The purpose of this study was to validate computed tomography measured ECV (ECVCT) as part routine evaluation for the detection cardiac amyloid in patients with aortic stenosis (AS)-amyloid. AS-amyloid affects 1 7 elderly referred transcatheter valve replacement (TAVR). Bone scintigraphy exclusion a plasma cell dyscrasia can diagnose transthyretin-related noninvasively, which novel treatments are emerging. Amyloid interstitial expansion increases myocardial extracellular volume (ECV)....

10.1016/j.jcmg.2020.05.029 article EN cc-by JACC. Cardiovascular imaging 2020-08-05
Coming Soon ...